JAN 04, 2021 9:23 AM PST

The most diverse genetic analysis of prostate cancer to date

Racial health disparities are glaringly obvious in the case of prostate cancer where the risk level is roughly 75% higher and the disease is more than twice as deadly in Black people compared to white people. Nevertheless, research studies often have an overrepresentation of white participants, meaning there are often gaps in data that ultimately act as obstacles for change-making processes.

That’s where a new study published in Nature Genetics from scientists at the USC Center for Genetic Epidemiology and the Institute for Cancer Research, London, enters the stage. The study comprises the largest, most diverse genetic analysis for prostate cancer to date, composed of data from over 200,000 men of European, African, Asian, and Hispanic ancestry.

"Our long-term objective is to develop a genetic risk score that can be used to determine a man's risk of developing prostate cancer," said corresponding author Christopher Haiman, ScD, who is both a professor of preventive medicine at the Keck School of Medicine of USC and director of the USC Center for Genetic Epidemiology. "Men at higher risk may benefit from earlier and more frequent screening, so the disease can be identified when it's more treatable."

Most significantly, the study contributed 86 previously unidentified genetic variations that increase risk for prostate cancer. Modeling the genetic risks revealed that men of African ancestry inherit roughly twice the prostate cancer risk on average compared to men of European ancestry, while men of Asian ancestry inherit about three-quarters the risk held by European descendants.

Photo: Pexels

This information has the potential to improve health equity and address concerns of healthcare disparities. It also opens up the door to using precision medicine for early detection and screening for prostate cancer.

"We not only found new markers of risk, but also demonstrated that, by combining genetic information across populations, we were able to identify a risk profile that can be applied across populations," said Haiman. "This emphasizes the value of adding multiple racial and ethnic populations into genetic studies.” Haiman hopes to carry out a large-scale clinical trial in order to put the team’s findings into practice. "Most important, unlike previous screening trials, this one would need to be more representative of the diversity we see in the world," Haiman concluded. "No population should get left behind."

Sources: Nature Genetics, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 29, 2021
Genetics & Genomics
As Humans Evolved, Cancer Came Along
JAN 29, 2021
As Humans Evolved, Cancer Came Along
Humans are far more likely to get several types of cancerous tumors than our closest evolutionary cousins, chimpanzees. ...
FEB 14, 2021
Cancer
Your daily commute exposes you to these two carcinogens
FEB 14, 2021
Your daily commute exposes you to these two carcinogens
New research from UC Riverside reports alarming findings on the risks of exposure to carcinogenic chemicals from time sp ...
MAR 03, 2021
Cancer
Multiple breast cancer screenings reduce mortality rates
MAR 03, 2021
Multiple breast cancer screenings reduce mortality rates
New research published in the journal Radiology reports on the advantages that multiple breast cancer screenings can hav ...
MAR 10, 2021
Cancer
Changes to lung cancer screening guidelines
MAR 10, 2021
Changes to lung cancer screening guidelines
In a revision of a ten-year-old lung cancer screening guideline that initially recommended low-dose CT (LDCT) screening ...
APR 01, 2021
Immunology
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
APR 01, 2021
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
Cancer researchers have developed a therapeutic vaccine for melanoma, a deadly form of skin cancer. Instead of protectin ...
APR 04, 2021
Drug Discovery & Development
Ion-Pump for Chemotherapy
APR 04, 2021
Ion-Pump for Chemotherapy
Patients of malignant brain tumors experience recurrences even after subsequent treatments. To address this issue, scien ...
Loading Comments...